(Q43267508)

English

Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy

scientific article published on 2 October 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1 reference

based on heuristic

inferred from title

author name string

Lei Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Yan Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Xiao Ting Lu

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Yi Ling Wu

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Cheng Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Xiao Ping Ji

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Rong Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Chun Xi Liu

8

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Jin Bo Feng

9

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Hong Jiang

10

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Xin Sheng Xu

11

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Yu Xia Zhao

12

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Yun Zhang

13

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

2 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

American Journal of Physiology Heart and Circulatory Physiology

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

297

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

H2004-14

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Update on therapeutic neovascularization

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

The pathophysiology of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Cardiovascular and airway relaxant activities of peony root extract

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Simvastatin reduces NF-kappaB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Pravastatin inhibits expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in Watanabe heritable hyperlipidemic rabbits: a new pleiotropic effect of statins

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

The ginsenoside-Rb2 lowers cholesterol and triacylglycerol levels in 3T3-L1 adipocytes cultured under high cholesterol or fatty acids conditions

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Stabilization of atherosclerotic plaques: new mechanisms and clinical targets

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Pathological mechanisms and dose dependency of erythrocyte-induced vulnerability of atherosclerotic plaques.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert [...]

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

C-reactive protein levels and outcomes after statin therapy

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Mechanisms of plaque vulnerability and rupture

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Statins promote potent systemic antioxidant effects through specific inflammatory pathways

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Protective effects of a compound herbal extract (Tong Xin Luo) on free fatty acid induced endothelial injury: implications of antioxidant system

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00208.2009

21 January 2018

Bioactive saponins and glycosides. XIV. Structure elucidation and immunological adjuvant activity of novel protojujubogenin type triterpene bisdesmosides, protojujubosides A, B, and B1, from the seeds of Zizyphus jujuba var. spinosa (Zizyphi Spinosi

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.47.1744

Identifiers

10.1152/AJPHEART.00208.2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43267508&oldid=2131105769"